Effects of a Resilience‐Building Energy Management Program on Fatigue and Other Symptoms in Systemic Sclerosis: A Randomized Controlled Trial
Arthritis Care & Research · 2024
DOI: 10.1002/acr.25253 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Arthritis Care & Research, 2024. Verfasst von Susan L Murphy und 12 weiteren Autor:innen. Beteiligte Einrichtung: University of Michigan, Ann Arbor. Hauptthemen laut MEDLINE: Resilience, Psychological, Scleroderma, Systemic, Psychological Tests. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: ACL HHS, NIAMS NIH HHS, National Institute of Arthritis and Musculoskeletal and Skin Diseases.
Abstract (Originalsprache)
Objective
Supported self‐management interventions for individuals with systemic sclerosis (SSc) are needed. We examined the effects of a 12‐week resilience‐building energy management program (called RENEW) for fatigue and other patient‐reported outcomes.
Methods
Participants, who had physician‐diagnosed SSc, moderate to severe fatigue, and were ≥18 years old, were randomly assigned to RENEW or waitlist control in a 2:1 ratio. The RENEW intervention included an educational website/application plus nine virtual peer‐led health coaching sessions. The primary outcome was change in the Functional Assessment of Chronic Illness Therapy‐Fatigue scale. Secondary outcomes were change in Patient Reported Outcomes Measurement Information System measures of pain interference and depressive symptoms and Connor‐Davidson Resilience Scale. Outcomes were assessed at baseline, 6 weeks, and 12 weeks. Multiple imputation was conducted; linear mixed models were used to assess group differences. A three‐way interaction with group, time, and SSc duration was examined in each model.
Results
Among 173 participants (mean ± SD age 54.5 ± 11.7 years; 93% female, 85% White), 47% had diffuse cutaneous SSc; 57% were ≤5 years from diagnosis. At 12 weeks, compared to controls, RENEW participants had a clinically meaningful fatigue improvement (β = −4.7; 95% confidence interval −6.7 to −2.7; P < 0.001) and improvement in all secondary outcomes. Among RENEW participants, individuals with shorter disease duration had greater improvements in fatigue at 12 weeks.
Conclusion
An mHealth supported self‐management intervention improved fatigue and other outcomes, particularly in newly diagnosed patients. This program may be broadly scalable for SSc symptom management. image
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- University of Michigan, Ann Arbor.
ORCID-Profile: Susan L Murphy, Afton L Hassett, Anna L Kratz, Alexandra E Harper, Dinesh Khanna
Förderung
- ACL HHS
- NIAMS NIH HHS
- National Institute of Arthritis and Musculoskeletal and Skin Diseases
- National Institute on Disability, Independent Living, and Rehabilitation Research
- Rheumatology Research Foundation
Zitieren
APA
Murphy, S. L., Chen, Y. T., Alore, M., Hicks, S., Pape, A., Hassett, A. L., Kratz, A. L., Whibley, D., Harper, A. E., Huang, S., Jay, G., Bolde, S., & Khanna, D. (2024). Effects of a Resilience‐Building Energy Management Program on Fatigue and Other Symptoms in Systemic Sclerosis: A Randomized Controlled Trial. Arthritis Care & Research. https://doi.org/10.1002/acr.25253
Vancouver
Murphy SL, Chen YT, Alore M, Hicks S, Pape A, Hassett AL, et al. Effects of a Resilience‐Building Energy Management Program on Fatigue and Other Symptoms in Systemic Sclerosis: A Randomized Controlled Trial. Arthritis Care & Research. 2024. doi:10.1002/acr.25253
BibTeX
@article{Murphy2024,
author = {Murphy, Susan L and Chen, Yen T and Alore, Mary and Hicks, Sheri and Pape, Adam and Hassett, Afton L and Kratz, Anna L and Whibley, Daniel and Harper, Alexandra E and Huang, Suiyuan and Jay, Gina and Bolde, Shannen and Khanna, Dinesh},
title = {Effects of a Resilience‐Building Energy Management Program on Fatigue and Other Symptoms in Systemic Sclerosis: A Randomized Controlled Trial},
journal = {Arthritis Care & Research},
year = {2024},
doi = {10.1002/acr.25253}
}
EUVIMED